Is it a good company at a reasonable price? I like dividend growth stocks. Although this stock has a high dividend yield it is not growing and every gain in yield subtracts from your capital investment. The total return on this stock has mostly been negative except for the last 5 year because 5 years ago, the stock price was relatively low at $8.07. This stock is totally dependent on one company Kruger Products L.P. The current dividend yield is quite high at over 8%. Results of my testing is showing that the stock price is relatively cheap.
I do not own this stock of KP Tissue Inc (TSX-KPT, OTC-KPTSF). This was a stock suggested by a speaker at the Ellen's Investment Club.
When I was updating my spreadsheet, I noticed this stock is complicated. They basically own shares in another company and only one. They have been around for over 11 years and the dividend has not changed. The stock price wanders around, but has never gone back to the original price. I do not really see why anyone would buy it. The dividends are good, with current 10 year median dividend yield at 6.4%
If you had invested in this company in December 2013, for $1,012.44 you would have bought 59 shares at $17.16 per share. In December 2023, after 10 years you would have received $424.80.21 in dividends. The stock would be worth $532.18. Your total return would have been $956.98. This would be a total loss of 0.70% per year with 6.23% from capital loss and 5.53% from dividends.
Cost | Tot. Cost | Shares | Years | Dividends | Stock Val | Tot Ret |
---|---|---|---|---|---|---|
$17.16 | $1,012.44 | 59 | 10 | $424.80 | $532.18 | $956.98 |
The current dividend yield is high with dividend growth non-existent. The dividend yield is high (7% or higher) at 8.82%. The 5, 10 and historical dividend yields are good (5% to 6% ranges) at 6.72%, 6.44% and 6.39%. There has no change in the dividends since this stock was listed approximately 10 years ago.
The Dividend Payout Ratios (DPR) are non-calculable. The chart below has all zeros because the payout rates cannot be calculated. The EPS show earning losses with a couple of exceptions. There is no cash flow for this stock. The Free Cash Flow is negative or zero or the same value as the dividends, depending on where you look for this value.
Item | Cur | 5 Years |
---|---|---|
EPS | 0.00% | 0.00% |
CFPS | 0.00% | 0.00% |
FCF | 0.00% | 0.00% |
Debt Ratios for KP Tissue Inc are fine, but it is wholly dependent on Kruger Products Inc. The Liquidity Ratio is low for 2023 at 1.09 and currently at 1.03. I prefer this to be at 1.50 or higher. The Debt Ratio is high for 2023 at 31.38 and currently at 33.55. This because the company has few liabilities compared to assets. However, this stock is wholly dependent on Kruger Products Inc. The Leverage and Debt/Equity Ratios for 2023 are good at 1.03 and 0.03 and currently at 1.03 and 0.03.
Type | Year End | Ratio Curr |
---|---|---|
Lg Term R | 0.00 | 0.00 |
Intang/GW | 0.00 | 0.00 |
Liquidity | 1.09 | 1.03 |
Liq. + CF | 0.26 | 0.24 |
Debt Ratio | 31.38 | 33.55 |
Leverage | 1.03 | 1.03 |
D/E Ratio | 0.03 | 0.03 |
Debt Ratios for Kruger Products Inc shows debt ratios are not good and that the debt is too high. The Long Term Debt/Market Cap Ratio cannot be calculated. The Liquidity Ratio for 2023 is too low at 1.09 and 0.97 currently. The Debt Ratio for 2023 is low at 1.36 and 1.36 currently. I like both these ratios to be 1.50 or higher. The Leverage and Debt/Equity Ratios for 2023 are too high at 3.79 and 2.79 and currently at 3.74 and 2.74. I prefer these ratios to be below 3.00 and 2.00
Type | Year End | Ratio Curr |
---|---|---|
Lg Term R | 0.00 | 0.00 |
Intang/GW | 0.08 | 0.07 |
Liquidity | 1.09 | 0.97 |
Liq. + CF | 0.00 | 0.00 |
Debt Ratio | 1.36 | 1.36 |
Leverage | 3.79 | 3.74 |
D/E Ratio | 2.79 | 2.74 |
The Total Return per year is shown below for years of 5 to 11 to the end of 2023. Under the Capital Gain column is the portion of the Total Return attributable to capital gains. Under the Dividend column is the portion of the Total Return attributable to dividends. See chart below.
From | Years | Div. Gth | Tot Ret | Cap Gain | Div. |
---|---|---|---|---|---|
2018 | 5 | 0.00% | 10.82% | 2.25% | 8.57% |
2013 | 10 | -0.50% | -0.70% | -6.23% | 5.53% |
2012 | 11 | -0.34% | -5.84% | 5.50% |
The 5-year low, median, and high median Price/Earnings per Share Ratios are negative and so useless in testing the stock price.
I get a Graham Price of $9.86. The 10-year low, median, and high median Price/Graham Price Ratios are 3.60, 5.11 and 6.28. The current P/GP Ratio is 0.83 based on a stock price of $8.16. This ratio is below the low ratio of the 10 year median ratios. This stock price testing suggests that the stock price is relatively cheap. However, I had to guess at what the Graham Price was in a lot of years, so this is not a good price.
I get a 10-year median Price/Book Value per Share Ratio of 1.21. The current ratio is 1.15 based on a stock price of $8.16, Book Value of $70.7M, and Book Value per Share of $7.09. The current ratio is 5% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I also have a Book Value per Share estimate for 2024 of $8.25. This implies a ratio of $0.99 and a Book Value of $82.2M. This ratio is 18% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively reasonable and below the median.
I cannot do a Price/Cash Flow per Share Ratio test as this company has no Cash Flow.
I get an historical median dividend yield of 6.39%. The current dividend yield is 8.82% based on dividends of $0.72 and stock price of $8.16. The current dividend yield is 38% above the historical median dividend yield. This stock price testing suggests that the stock price is relatively cheap.
I get a 10 year median dividend yield of 6.44%. The current dividend yield is 8.82% based on dividends of $0.72 and stock price of $8.16. The current dividend yield is 37% above the 10 year median dividend yield. This stock price testing suggests that the stock price is relatively cheap.
The 10-year median Price/Sales (Revenue) Ratio is 0.10. The current P/S Ratio is 0.04 based on Revenue of $2034M, Revenue per Share of $203.94 and a stock price of $8.16. The current ratio is 60% below the 10 year median ratio. This stock price testing suggests that the stock price is relatively cheap.
Results of stock price testing is that the stock price is probably cheap. The Dividend Yield tests show that the stock price is cheap. The P/S Ratio test says that the stock price is cheap and confirms the Dividend Yield tests. Whatever testing I can do is showing the stock price as cheap or reasonable.
When I look at analysts’ recommendations, I find only Holds (4). The consensus would be a Hold. The 12 month stock price of $9.13, with a high of $10 and low of $8.50. The 12 month stock price of $9.13 implies a total return of 20.71 with 11.89% from capital gains and 8.82% in dividends.
The last analysts’ comments on Stock Chase in August 2023 and it was a Do Not Buy. Little coverage. Stock Chase gives this stock 1 star out of 5. Amy Legate-Wolfe on Motley Fool says high dividend yield is appealing but is considered that the dividend is no safe. Joey Frenette on Motley Fool thought in February 2023, you might want to buy this stock for passive dividend income. The company put out a press release on Newswire about their fourth quarter of 2023 results. The company put out a press release on Newswire about their third quarter of 2024 results .
GuruFocus News via Yahoo Finance put out a report on this stock. There is no review by Simply Wall Street. However, Simply Wall Street give this stock 3 and one half stars out of 5. Simply Wall Street gives 3 warnings makes less than USD$1m in revenue (CA$0); does not have a meaningful market cap (CA$81M); and significant insider selling over the past 3 months.
KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems. Its web site is here KP Tissue Inc.
The last stock I wrote about was about was Maple Leaf Foods Inc (TSX-MFI, OTC-MLFNF) ... learn more. The next stock I will write about will be Agnico Eagle Mines Ltd (TSX-AEM, NYSE-AEM) ... learn more on Monday, December 23, 2024 around 5 pm.
This blog is meant for educational purposes only and is not to provide investment advice. I am not a licensed professional investment advisor. Before making any investment decision, you should always do your own research or consult an investment professional. I do research for my own edification and I am willing to share. I write what I think and I may or may not be correct.
See my site for an index to these blog entries and for stocks followed. I have three blogs. The first talks only about specific stocks and is called Investment Talk. The second one contains information on mostly investing and is called Investing Economics Mostly. My last blog is for my book reviews and it is called Non-Fiction Mostly. Follow me on Twitter. I am on Instagram. Or you can just Google #walktoronto spbrunner8166 to see my pictures.